What is the best medication for treating panic attacks?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Best Medication for Panic Attacks

Selective serotonin reuptake inhibitors (SSRIs) are the first-line treatment for panic attacks, with sertraline being a particularly effective and well-tolerated option. 1, 2

First-Line Treatments

SSRIs

  • SSRIs are the standard first-line pharmacological treatment for panic disorder due to their:

    • Proven efficacy in multiple controlled trials
    • Favorable side effect profile
    • Low risk of dependence
    • Long-term effectiveness 1, 2
  • Recommended SSRIs include:

    • Sertraline: 50-175 mg/day (start at 25-50 mg/day)
    • Escitalopram: 20 mg/day
    • Paroxetine: 20-50 mg/day
    • Fluoxetine: 20-50 mg/day 1, 3

Sertraline has particularly strong evidence for panic disorder, with demonstrated efficacy in reducing severity and frequency of panic attacks and providing protection from relapse for up to 36 weeks following discontinuation 3.

SNRIs

  • Venlafaxine is an effective alternative to SSRIs with comparable efficacy but may have more noradrenergic side effects 1

Second-Line and Adjunctive Treatments

Benzodiazepines

  • Benzodiazepines (e.g., alprazolam) should be reserved for:
    • Short-term use (1-4 weeks)
    • Adjunctive therapy during SSRI initiation
    • Treatment-resistant cases without history of substance dependence 1, 4, 5

Alprazolam has demonstrated efficacy in controlled studies for panic disorder, with doses of 2-6 mg/day showing superiority to placebo in reducing panic attacks 6.

Other Options

  • Pregabalin has shown efficacy for social anxiety disorder with faster onset than SSRIs 1
  • Tricyclic antidepressants (TCAs) are as effective as SSRIs but less well tolerated 4, 2
  • Non-benzodiazepine anxiolytics (e.g., buspirone) can be used as alternatives 1

Treatment Algorithm

  1. Initial Treatment:

    • Start with an SSRI (preferably sertraline 25-50 mg/day, titrating to 50-175 mg/day)
    • Consider short-term benzodiazepine (e.g., alprazolam) for immediate symptom relief during the first 2-4 weeks while waiting for SSRI effect
  2. After 4-6 weeks:

    • If responding: Continue SSRI for at least 9-12 months after recovery 7
    • If partial response: Optimize SSRI dose
    • If inadequate response: Switch to another SSRI or an SNRI
  3. For treatment-resistant cases:

    • Consider combination therapy
    • Consider augmentation with cognitive behavioral therapy (CBT)

Important Considerations

  • SSRIs may take 4-6 weeks to reach full therapeutic effect
  • Initial SSRI treatment may temporarily worsen anxiety symptoms in some patients
  • Benzodiazepines provide rapid relief but carry risks of tolerance and dependence 5
  • Treatment should continue for at least 9-12 months after symptom resolution to prevent relapse 7
  • Combining medication with cognitive behavioral therapy provides the most successful treatment strategy 4, 2

Special Populations

  • For patients with high baseline panic severity, sertraline remains effective but may show slightly less improvement on global scales 8
  • Sertraline is effective regardless of agoraphobia diagnosis, illness duration, or gender 8
  • Lower starting doses and slower titration are recommended in elderly patients 1

Common Pitfalls to Avoid

  1. Stopping medication too soon (should continue for at least 9-12 months after recovery)
  2. Using benzodiazepines as sole long-term treatment
  3. Failing to warn patients about potential initial worsening of anxiety with SSRIs
  4. Not providing adequate follow-up during medication transitions
  5. Overlooking the value of combining pharmacotherapy with CBT

By following this evidence-based approach, most patients with panic attacks can achieve significant symptom reduction and improved quality of life.

References

Guideline

Social Anxiety Disorder Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Management of panic disorder.

Expert review of neurotherapeutics, 2005

Research

Sertraline in the treatment of panic disorder.

Drugs of today (Barcelona, Spain : 1998), 2009

Research

Pharmacological treatment of panic disorder.

Modern trends in pharmacopsychiatry, 2013

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.